Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Fecal Incontinence And Quality Of Life
Fecal incontinence (FI) is a normal part of aging, or the perception that no treatment is available. Doctors may fail to comprehend patient hints about diarrhea and FI or may be reluctant to ask about fecal leakage, perhaps because of their own embarrassment or the perception that FI is a trivial concern.
generic viagra online
Key Event In Prostate Cancer Progression Discovered By Scientists
A study led by researchers at the Ohio State University Comprehensive Cancer Center and Dana-Farber Cancer Institute reveals how late-stage, hormone-independent prostate tumors gain the ability to grow without need of hormones.
News of the day
Oklahoma Antiabortion Lawmakers Try To Revive Vetoed Bill To Ban Stem Cell Research
Antiabortion lawmakers in Oklahoma on Wednesday attempted to revive vetoed legislation that would have banned embryonic stem cell research in the state by adding the ban to an unrelated bill (HB 1114) that would prohibit human cloning, the AP/CNBC.com reports. House members on Wednesday also added a prohibition on human cloning to that measure. According to Tony Lauinger, chair of Oklahomans for Life, the measure is "narrower" than the vetoed bill and would "ban reproductive cloning, as well as the creation of human embryos for the purpose of harvesting their stem cells."Gov. Brad Henry (D) had vetoed the measure that would have banned stem cell research three weeks ago. The veto subsequently was overwridden by the House and sustained by the Senate. The House on Wednesday also voted 88-6 to approve a measure (HB 1595) that would ban gender selection for genetically modified embryos and ban sex-selective abortions. The measure also would require physicians who perform abortions to report abortion-related information to the state Department of Health. In addition, the bill would require the department to publish annual abortion reports on its Web site and conduct periodic inspections of abortion clinics (AP/CNBC.com, 5/14).
Cardiovascular

Victorian HIV Test To Help Monitor Sufferers

People living with HIV will benefit from a new test developed by Victoria, Australia scientists that offers a simpler and cheaper way of monitoring the disease in sufferers, Victorian Innovation Minister Gavin Jennings said today. The test, developed by researchers at the Melbourne-based Macfarlane Burnet Institute, provides a simple way for clinicians to monitor the key CD4 T-cells in people with HIV. These cells are used as an accurate marker of the disease"s progression because HIV targets these cells, reducing their levels and weakening the immune system which can result in the onset of AIDS. "The Victorian Government is taking action to promote health and lifestyle benefits through biotech initiatives, such as this new HIV test, which will also create jobs for Victorians," Mr. Jennings said. "This test is good news for the 40 million people worldwide diagnosed with HIV - a virus that continues to grow by three million new cases each year. The current monitoring approach using flow cytometry is expensive, complex and only available in major laboratories. The ELISA (enzyme-linked immunosorbent assay) test addresses an unmet need for a lower-cost, simpler and higher throughput technology suitable for routine use in pathology laboratories." The researchers behind the ELISA-based test, led by Associate Professor David Anderson and Professor Suzanne Crowe, have formed a spinout company, SeeD4, and have received funding of $377,000 from the Medical Research Commercialisation Fund (MRCF), a $30 million fund supported by the Victorian Government, for ongoing development. Mr. Jennings announced the innovation at the international BIO2009 conference in Atlanta, USA, ahead of a keynote address on HIV/AIDS initiatives by Sir Elton John. "The management of HIV and the use of antiviral therapies require the regular monitoring of circulating CD4 T-cells in patients, that"s why this test is so important," Mr. Jennings said. "The measurement of CD4 T-cell levels is initially used to determine when patients should commence treatment. Once on treatment, CD4 T-cells are regularly monitored to ensure that the viral load is effectively managed and that the virus has not become resistant to therapy." The MRCF investment will enable completion of the testing and clinical evaluation, including a head-to-head comparison with the flow cytometry method. The technology was developed to an initial validation stage with funding provided by the Doris Duke Charitable Foundation and the National Health and Medical Research Council. Victoria


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009